Correlation Between NRX Pharmaceuticals and Spero Therapeutics
Can any of the company-specific risk be diversified away by investing in both NRX Pharmaceuticals and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NRX Pharmaceuticals and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NRX Pharmaceuticals and Spero Therapeutics, you can compare the effects of market volatilities on NRX Pharmaceuticals and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NRX Pharmaceuticals with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NRX Pharmaceuticals and Spero Therapeutics.
Diversification Opportunities for NRX Pharmaceuticals and Spero Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between NRX and Spero is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding NRX Pharmaceuticals and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and NRX Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NRX Pharmaceuticals are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of NRX Pharmaceuticals i.e., NRX Pharmaceuticals and Spero Therapeutics go up and down completely randomly.
Pair Corralation between NRX Pharmaceuticals and Spero Therapeutics
Given the investment horizon of 90 days NRX Pharmaceuticals is expected to under-perform the Spero Therapeutics. In addition to that, NRX Pharmaceuticals is 2.6 times more volatile than Spero Therapeutics. It trades about -0.03 of its total potential returns per unit of risk. Spero Therapeutics is currently generating about -0.02 per unit of volatility. If you would invest 138.00 in Spero Therapeutics on September 14, 2024 and sell it today you would lose (31.00) from holding Spero Therapeutics or give up 22.46% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.6% |
| Values | Daily Returns |
NRX Pharmaceuticals vs. Spero Therapeutics
Performance |
| Timeline |
| NRX Pharmaceuticals |
| Spero Therapeutics |
NRX Pharmaceuticals and Spero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NRX Pharmaceuticals and Spero Therapeutics
The main advantage of trading using opposite NRX Pharmaceuticals and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NRX Pharmaceuticals position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.| NRX Pharmaceuticals vs. Biomx Inc | NRX Pharmaceuticals vs. Lexaria Bioscience Corp | NRX Pharmaceuticals vs. Aditxt Inc | NRX Pharmaceuticals vs. Nutriband |
| Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |